SCHOTT Pharma AG & Co. KGaA (1SXP) — Free Cash Flow Generation Index
SCHOTT Pharma AG & Co. KGaA (1SXP) has a Free Cash Flow Generation Index of 0.15x as of September 2024. Free cash flow of €11.29 Million represents 0% of operating cash flow (€75.97 Million). Explore capital reinvestment ratio of SCHOTT Pharma AG & Co. KGaA to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
SCHOTT Pharma AG & Co. KGaA Free Cash Flow Generation Index (2020–2024)
Historical FCF Generation Index trend for SCHOTT Pharma AG & Co. KGaA across 5 annual periods. For the full cash flow conversion analysis, see 1SXP operating cash flow.
Annual Free Cash Flow Generation for SCHOTT Pharma AG & Co. KGaA (2020–2024)
Year-by-year Free Cash Flow Generation Index for SCHOTT Pharma AG & Co. KGaA. Check total reinvestment intensity of SCHOTT Pharma AG & Co. KGaA to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.36x | €80.03 Million | €225.33 Million | €145.30 Million | ▲ +952.8% |
| 2023 | 0.03x | €6.13 Million | €181.65 Million | €175.52 Million | ▼ -79.1% |
| 2022 | 0.16x | €29.43 Million | €182.12 Million | €152.69 Million | ▼ -36.4% |
| 2021 | 0.25x | €33.59 Million | €132.21 Million | €98.63 Million | ▲ +38.9% |
| 2020 | 0.18x | €19.09 Million | €104.40 Million | €85.31 Million | — |